| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/05/2008 | WO2007119180A3 Survival and development of neural cells |
| 06/05/2008 | WO2007107442A3 Bis1,2,3,4-tetrahydroisoquinoline derivatives and their uses as pharmaceuticals |
| 06/05/2008 | WO2007073178A3 Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition |
| 06/05/2008 | WO2007035405A3 In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
| 06/05/2008 | US20080132830 Separable solid dosage form administration system |
| 06/05/2008 | US20080132825 Transcutaneous infusion of carbon dioxide for local relief of pain and other ailments |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132704 3-Substituted quinuclidines and their use |
| 06/05/2008 | US20080132578 venlafaxine metabolites used for treating and preventing psychological disorders, Parkinson's disease, epilepsy, obesity, incontinence or Alzheimer's disease; side effect reduction |
| 06/05/2008 | US20080132570 Levodopa prodrugs, and compositions and uses thereof |
| 06/05/2008 | US20080132562 Tetronic and tetramic acids |
| 06/05/2008 | US20080132559 2-(2-aminobenzoyl)-N-2-nitro-4-methylsulfonyl-phenylethylamine; glycogen synthase kinase-3 (GSK3 beta inhibitor and NMDA channel modulator; neurodegenerative diseases, type II diabetes, anticarcinogenic agent |
| 06/05/2008 | US20080132552 e.g. N-[1-(3,5-Difluoro-benzyl)-2-hydroxy-3-methylamino-propyl]-5-methyl-N',N'-dipropyl-isophthalamide; beta-secretase inhibitor; neurodegenerative diseases: Alzheimer's disease |
| 06/05/2008 | US20080132551 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 06/05/2008 | US20080132540 Such as trans-N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-N-(1-benzyl-piperidin-4-yl)-3-phenyl-acrylamide; for treating/preventing anxiolytic disorders/depression, injured mammalian nerve tissue, conditions, neurological disorders, bone loss, substance related disorders, and obesity; neuropeptide y (NPY Y2) |
| 06/05/2008 | US20080132531 Synergistic combinations of norketamine and opioid analgesics |
| 06/05/2008 | US20080132520 Compositions, kits and methods for administering a titration schedule comprising bifeprunox compounds |
| 06/05/2008 | US20080132518 novel polymorphic forms of aripiprazole in the treatment of schizophrenia; properties suitable for pharmaceutical processing on a commercial scale |
| 06/05/2008 | US20080132514 bi-functional organic molecules which combine serotonin transporter reuptake inhibition with serotonin (5-HT, such as 5-HT2A) receptor antagonism in one molecular entity |
| 06/05/2008 | US20080132505 Combination Of Cb2 Modulators And Pde4 Inhibitors For Use In Medicine |
| 06/05/2008 | US20080132494 Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
| 06/05/2008 | US20080132493 Aqueous cyclodextrin-free solution; analgesics, antiinflammatories, antipyretics |
| 06/05/2008 | US20080132492 Use of Flumazenil in the Production of a Drug for the Treatment of Alcohol Dependency |
| 06/05/2008 | US20080132489 1-aryl-alkyl-substituted-1,4-diazepine derivatives; 1-(4-Chloro-3-methoxy-phenyl)-3,3,5,5-tetramethyl-[1,4]diazepane for example; antidepressants, analgesics, various psychological disorders, dementia, eating disorders, drug abuse; side effect reduction |
| 06/05/2008 | US20080132488 Prodrugs of (2R)-2-Propyloctanoic Acid For the Treatment of Stroke |
| 06/05/2008 | US20080132486 Ligands for Nicotinic Acetylcholine Receptors, and Methods of Making and Using Them |
| 06/05/2008 | US20080132483 Administering (3R,5S)-N-propanesulfonyl-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetamide; cerebral infarction |
| 06/05/2008 | US20080132479 Oxime Derivative and Preparations Thereof |
| 06/05/2008 | US20080132476 Administering e.g. 17beta-Fluoro-9alpha-vinyl-estra-1,3,5(10)-triene-3,16alpha-diol to treat endometriosis, osteoporosis, or hormone replacement therapy in combination with other drugs |
| 06/05/2008 | US20080132473 Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology |
| 06/05/2008 | US20080132472 Compounds for the treatment of psychiatric or substance abuse disorders |
| 06/05/2008 | US20080132460 Screening for a compound which inhibits p62/ubiquitin binding; detecting the formation of inclusion bodies in neurodegenerative diseases; screening for therapeutic agents that disperse the inclusions |
| 06/05/2008 | US20080132455 Process For Producing Enriched Fractions Containing Up To 100% Of Bacopasaponins From The Plant Materials Of Bacopa Species |
| 06/05/2008 | US20080132450 Pharmaceutical composition for suppression of apoptosis and method for delivering the same |
| 06/05/2008 | US20080132446 Uses of neuronal pannexins for therapy and diagnosis in mammals |
| 06/05/2008 | US20080132441 Methods and compositions for modulating medial-lateral neuronal topographic maps |
| 06/05/2008 | US20080131871 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
| 06/05/2008 | US20080131532 Fast asleep |
| 06/05/2008 | US20080131530 Composition Comprising the Extract of Crude Drug Complex Having Neuroprotective Activity For Preventing and Treating Stroke and Neurodegenerative Diseases |
| 06/05/2008 | US20080131528 Methods and compositions for treating or preventing neurodegenerative diseases |
| 06/05/2008 | US20080131516 Granule formation |
| 06/05/2008 | US20080131508 Oral transmucosal nicotine dosage form |
| 06/05/2008 | US20080131501 enhanced immediate release formulations of topiramate, in which 80% of the active ingredient is released in the period of time of not more than 30 min. These formulations may be advantageously used for the treatment of acute neurological conditions, such as migraine. |
| 06/05/2008 | US20080131500 methods of inactivating a protein, such as cleaving a disulfide bond of a protein, that involve contacting the protein with a reducing agent, a denaturant, and a hydroxide ion, wherein the pH of the composition is about 10.0 to about 14.0. Also disclosed are methods of treating or preventing a disease |
| 06/05/2008 | US20080131490 Stabilized donepezil-containing patch preparation |
| 06/05/2008 | US20080131483 Enhancement of Drug Delivery to the Central Nervous System |
| 06/05/2008 | US20080131448 Using interleukin receptor as tool in treatment cell proliferative disorders; antitumor agents |
| 06/05/2008 | US20080131437 Using allelic variation in cell adhesion molecule (CD164) as tool in treatment and prevntion of skin, arthritic and gastrointestinal disorders |
| 06/05/2008 | US20080131422 Brain protein specific immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease |
| 06/05/2008 | US20080131416 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders |
| 06/05/2008 | US20080131410 Placental stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| 06/05/2008 | US20080131409 Methods and compositions for the treatment of medical disorders |
| 06/05/2008 | US20080131407 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 06/05/2008 | US20080131405 Composition for treating a disease caused by neuronal insult comprising a human umbilical cord blood-derived mesenchymal stem cell as an active ingredient |
| 06/05/2008 | US20080131400 Vector system |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | US20080131370 For prophylaxis or treatment of apoptosis or inflammation-associated disease, diabetes, or chronic obstructive pulmonary disease |
| 06/05/2008 | DE60129697T2 Kondensierte azepinderivate und ihre verwendung als antidiuretisches mittel Condensed azepine derivatives and their use as antidiuretic agent |
| 06/05/2008 | DE102006056783A1 Zubereitung zur transdermalen Verabreichung von Galanthamin Preparation for transdermal administration of galanthamine |
| 06/05/2008 | DE102006056697A1 Galanthamin-haltiges Arzneimittel mit kontrollierter Freisetzung Galanthamine-containing pharmaceutical controlled release |
| 06/05/2008 | CA2672273A1 Methods for the treatment of alcohol abuse, addiction and dependency |
| 06/05/2008 | CA2671081A1 Stabilized adhesive preparation containing donepezil |
| 06/05/2008 | CA2671006A1 Method for suppressing discoloration over time of adhesive preparation containing donepezil |
| 06/05/2008 | CA2671000A1 Method for suppressing coloring of adhesive preparation containing donepezil and method for reducing amounts of donepezil-related substances formed |
| 06/05/2008 | CA2670995A1 Stabilized adhesive preparation containing donepezil |
| 06/05/2008 | CA2670991A1 Percutaneously absorbable preparation comprising donepezil |
| 06/05/2008 | CA2670984A1 Novel curcumin derivative |
| 06/05/2008 | CA2670957A1 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 06/05/2008 | CA2670858A1 Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one |
| 06/05/2008 | CA2670573A1 Diaminocyclohexane and diaminocyclopentane derivatives |
| 06/05/2008 | CA2670116A1 Methods of treating mental retardation, down's syndrome, fragile x syndrome and autism |
| 06/05/2008 | CA2669060A1 Piperidine compounds |
| 06/05/2008 | CA2668811A1 Methods of treating cognitive impairment and dementia |
| 06/05/2008 | CA2668808A1 (s)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use |
| 06/05/2008 | CA2668579A1 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 06/04/2008 | EP1927367A1 Novel pharmaceutical using anti-hla antibody |
| 06/04/2008 | EP1927366A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (RSV) |
| 06/04/2008 | EP1927357A2 Low hygroscopic aripiprazole (crystal E) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1927356A1 Low hygroscopic aripiprazole (crystal D) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1927355A1 Low hygroscopic aripiprazole (crystal F) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1927352A2 Therapeutic methods and compositions involving isoflavones |
| 06/04/2008 | EP1927351A1 Use of agomelatine to obtain medication aimed at treating periventricular leukomalacia |
| 06/04/2008 | EP1927348A1 Anticonvulsive pharmaceutical compositions |
| 06/04/2008 | EP1926731A2 Amino-aza-adamantane derivatives and methods of use |
| 06/04/2008 | EP1926723A2 Azabicyclo (3,1,0) hexan derivatives useful as modulators of dopamine d3 rceptors |
| 06/04/2008 | EP1926721A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 06/04/2008 | EP1926719A2 2-aniline-4-aryl substituted thiazole derivatives |
| 06/04/2008 | EP1926712A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 06/04/2008 | EP1926488A2 Combination of rosiglitazone and donepezil for improvement of cognitive function |
| 06/04/2008 | EP1926483A2 Treatment of autoimmune diseases |
| 06/04/2008 | EP1756086B1 Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists |
| 06/04/2008 | EP1592687B1 Benzofurane derivatives and the use of the same as antidepressants and anxiolytics |
| 06/04/2008 | EP1487817B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 06/04/2008 | EP1474119B1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta |
| 06/04/2008 | EP1463754B1 Cystine-knot fold protein |
| 06/04/2008 | EP1456357B1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 06/04/2008 | EP1395591B1 Corticotropin releasing factor antagonists |
| 06/04/2008 | EP1354951B1 Method of examining ability to control nerve cell plasticity |
| 06/04/2008 | EP1343775B1 Piperazine derivatives |
| 06/04/2008 | EP1339669B1 N-alkylated gaba compounds, processes for their preparation and their use as medicaments |